The Anti-Inflammatory Effect of ACE-I/ARBs Drug on hs-CRP and HDL-Cholesterol in CKD Patient

• Main Authors: Muhammad Iqbal Mubarok, -, Maftuchah Rochmanti, -, Mochamad Yusuf Alsagaff, -, Mochammad Thaha, -
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Medico Legal Society 2021
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/126354/1/27.%20The%20Anti-Inflammatory%20Effect%20of%20ACE-IARBs%20Drug%20on%20hs-CRP%20and%20HDL-Cholesterol%20in%20CKD%20Patient_Indian%20Journal%20of%20Forensic%20Medicine%20%26%20Toxicology%202021.pdf; https://repository.unair.ac.id/126354/2/karil%2027.pdf; https://repository.unair.ac.id/126354/3/27.%20Turnitin.pdf; https://repository.unair.ac.id/126354/; https://medicopublication.com/index.php/ijfmt/article/view/15878; https://doi.org/10.37506/ijfmt.v15i3.15878
• Institution: Universitas Airlangga

Chronic kidney disease (CKD) is progressive disease that closely related to the chronic inflammatory process. Angiotensin-Converting Enzyme Inhibitor (ACE-I)/Angiotensin Receptor Blockers (ARBs) is the main therapy in the management of CKD, based on the recent sudies stated that this drug have ple...